Clinical Trial Update: RESCUE Study - Everolimus in Liver Transplantation Recipients With Renal Insufficiency [Phase 3]

View source ↗

Summary

The RESCUE Phase 3 trial evaluated Everolimus in liver transplant recipients with renal insufficiency. The study is completed and results were posted in 2011.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Liver Transplantation

Drugs mentioned

• Everolimus (everolimus)

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Liver Transplantation | Phase 3 | Status: COMPLETED | Results posted: 2011-04-07